Skip to main content

Table 3 Ratios between prototype Th1:Th2 and pro-: anti-inflammatory cytokines.

From: Intermittent preventive treatment with sulfadoxine-pyrimethamine does not modify plasma cytokines and chemokines or intracellular cytokine responses to Plasmodium falciparum in Mozambican Children

   5 months 9 months 12 months 24 months
   Ratio 95% CI Ratio 95% CI Ratio 95% CI Ratio 95% CI
  Overall 32 31.73 - 32.27 39 38.73 - 39.27 25 24.69 - 25.31 71 70.75 - 71.25
IFN-γ:IL-4 SP 26 25.64 - 26.36 32 31.62 - 32.38 21 20.61 - 21.39 56 55.62 - 56.38
  Placebo 40 39.62 - 40.38 49 48.62 - 49.38 31 30.54 - 31.46 91 90.68 - 91.32
  Overall 14 13.80 - 14.20 8 7.79 - 8.21 8 7.78 - 8.22 4 3.69 - 4.31
TNF:IL-10 SP 13 12.71 - 13.29 8 7.73 - 8.27 8 7.70 - 8.30 4 3.58 - 4.42
  Placebo 14 13.73 - 14.27 8 7.69 - 8.31 8 7.67 - 8.33 5 4.55 - 5.45